News and Trends 2 May 2023
Astellas eyes ophthalmology field with $5.9B Iveric Bio takeover
Astellas Pharma Inc., through Berry Merger Sub, Inc., a wholly-owned subsidiary of Astellas US Holding, Inc., has agreed to acquire 100% of the outstanding shares of Iveric Bio, Inc., for…